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ABSTRACT
Background: Although many patients who experience chest pain or pressure consult their physicians, unfor-
tunately a large number of them do not, and consequently they remain undiagnosed and untreated. Chest pain,
in a subset of these patients, may be relieved with a bronchodilator or other asthma drugs.
Methods: This retrospective study included twenty cases of chest pain that were relieved with asthma drugs.
Chest pain was categorized into three types: chest pain variant asthma, bronchial asthma with chest pain, and
non-asthmatic allergic chest pain. Chest pain variant asthma was defined as chest pressure that improved in
response to a bronchodilator, without the characteristic attacks of bronchial asthma. Bronchial asthma with
chest pain was defined as chest pressure, with the characteristic attacks of bronchial asthma that improved fol-
lowing the administration of a leukotriene receptor antagonist, systemic corticosteroid, or bronchodilator. Non-
asthmatic allergic chest pain was defined as chest pressure without the typical asthma attack, but with chest
pressure that improved in response to a leukotriene receptor antagonist or systemic corticosteroid, but not a
bronchodilator.
Results: Fourteen cases of chest pain were diagnosed as variant asthma, three cases were diagnosed as
bronchial asthma with chest pain, and three cases were diagnosed as non-asthmatic allergic chest pain.
Conclusions: The results suggest that the mechanism underlying chest pain that is relieved with asthma
drugs can involve either an airway constriction pathway or a non-constrictive pathway presumably airway in-
flammation. Analysis of the patient’s response to treatment with asthma medication is useful for the correct di-
agnosis of the source of chest pain.
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INTRODUCTION
Many patients who experience chest pain consult
physicians and are usually diagnosed as having respi-
ratory (pneumothorax, pleuritis, pulmonary embo-
lism, etc.), coronary (myocardial infarction, angina
pectoris, etc.), or gastrointestinal (reflex esophagitis,
gastric ulcer, etc.) diseases. However, many patients
remain undiagnosed.
There are several reports of chest pain variant
asthma as a variant form of bronchial asthma.1-7 This
condition presents with chest pressure that improves
in response to treatment with a bronchodilator. How-
ever we have found cases with chest pressure who
improved following the administration of a leukot-
riene receptor antagonist, but not a bronchodilator,
inconsistent with the feature of chest pain variant
asthma. Therefore, a subset of patients with chest
pain of unknown origin can be successfully treated
with the use of a bronchodilator or other asthma
drugs. Since chest pain which improves following the
administration of asthma drugs is relatively uncharac-
terized, we examined twenty cases of such chest pain
and propose new clinical entities other than chest
pain variant asthma.
METHODS
Twenty patients diagnosed with chest pain that was
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chest pain (rule out pneumothorax, an infection, coronary disease, 
or gastrointestinal diseases)
chest pain variant
asthma
bronchial asthma 
with chest pain
non-asthmatic 
allergic chest pain other chest pain
inhalation of β2-stimulant during chest pain
effective not effective
effective not effective
have typical asthma attack? have typical asthma attack?
leukotriene receptor antagonist
or systemic corticosteroids
No NoYes Yes
Fig. 1 Schematic algorithm to treat patients with chest pressure of unknown etiology.
relieved with the use of asthma drugs at the Toyama
Prefectural Central Hospital between November 2006
and March 2008 were studied retrospectively. The
primary complaints of all patients included chest
pressure. Most patients received a chest X-ray, labo-
ratory diagnostics, an electrocardiogram, sublingual
administration of nitroglycerin, and an upper gastro-
intestinal endoscopy to verify that they were not suf-
fering from pneumothorax, an infection, coronary dis-
ease, or gastrointestinal diseases. Patients received a
bronchodilator (0.03 mg of procaterol hydrochloride,
a short acting β2-stimulant) via inhalation during
chest pain. If no change in the symptom was ob-
served after inhalation, we administered a cysteinyl
leukotriene receptor antagonist (10 mgday of mon-
telukast) for a week. If no change in the symptoms
was observed after the administration of a cysteinyl
leukotriene receptor antagonist, we then adminis-
tered a systemic corticosteroid (approximately 0.4―
0.5 mgkgday of prednisolone) for a week. The pa-
tients were given a diagnosis following a positive re-
sponse to the inhalation of a bronchodilator or a cys-
teinyl leukotriene receptor antagonist or a systemic
corticosteroid (Fig. 1).
The twenty patients were placed into three catego-
ries: “chest pain variant asthma,” “bronchial asthma
with chest pain,” and “non-asthmatic allergic chest
pain”. There are no clear diagnostic criteria estab-
lished for chest pain variant asthma,3 but it is defined
here as chest pressure (without the characteristic at-
tacks of bronchial asthma) that improves in response
to treatment with a bronchodilator. Cases that pre-
sented with the characteristic attacks of bronchial
asthma with chest pressure that improved following
the administration of a leukotriene receptor antago-
nist, systemic corticosteroid, or bronchodilator were
defined as bronchial asthma with chest pain. We de-
fined the characteristic asthma attack as recurrent
episodes of wheezing and breathlessness, which are
reversible either spontaneously or with treatment.
Cases presenting without an asthma attack but hav-
ing persistent or recurrent chest pressure that im-
proved in response to a leukotriene receptor antago-
nist or systemic corticosteroid, but not a bronchodila-
tor, were defined as non-asthmatic allergic chest pain.
This study was approved by the ethics committee at
the Toyama Prefectural Central Hospital.
RESULTS
The twenty cases of chest pain relieved with asthma
drugs are summarized in Table 1―4. Fourteen cases
were diagnosed as chest pain variant asthma, three
were diagnosed as bronchial asthma with chest pain,
and three were diagnosed as non-asthmatic allergic
chest pain (Table 1). The average age at onset of
chest pain was 36.1 years, and the male : female sex
ratio was 1 : 1. Fluoroenzymeimmunoanalyses (Uni-
CAPⓇ) specific immunoglobulin E studies were per-
formed in seventeen patients, nine of whom were
positive.
The primary complaints from the patients included
substernal pressure in thirteen patients and deep
inspiration-induced chest pressure in four patients
(cases 4, 8, 9, and 17). Interestingly, case 3 experi-
enced right head pressure in association with right
chest pressure. Only two cases (cases 5 and 8) re-
ported dyspnea in association with the chest pressure
attacks.
Chest Pain Relieved with Asthma Drugs
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Table 1 Characteristics of chest pain relieved with asthma drugs in twenty patients (1)
Aspects of chest pain 
atackChief complaints
Past
 history
UniCAP 
specific
IgE †
Serum
 IgE
 (IU/ml)
Age of 
diagnosis
Age of
onsetSexNo.
(chest pain variant asthma)
lasted from 2 hours to 
half a day in the morning
substernal pressure, 
chest discomfort
atopic 
dermatitis+7,3653737M 1
induced by smoking,
lasted 15 minutes,
a few times a day
substernal pressurechildhood asthma2424M 2
severe pain lasted 
 5 minutes, and 
mild pain around it
substernal and right chest 
pressure, headache3734M 3
severe pain lasted
5 minutes, a few
times a day
substernal pressure 
induced by deep 
inspiration, dyspnea
-294747M 4
lasted al day,
severe pain
substernal pressure, 
dyspnea-483232F 5
lasted 20 minutes
in the morning,
once a few days
substernal pressure-916240M 6
lasted al day,
severe painsubsternal pressure-105858F 7
lasted al day
right chest pressure
induced by deep
inspiration, dyspnea
childhood
 asthma+4401717M 8
lasted al day
left chest pressure
induced by deep
 inspiration
+7931717M 9
lasted for a few hours,
a few times a day
left chest pressure,
cough
alergic
rhinitis-933030M10
lasted al dayright chestpressure-177171F11
lasted an hour,
many times a dayright chest pressure+3138120F12
lasted al dayupper chest andthroat pressure6666F13
lasted a minute,
a few times a monthsubsternal pressure+132516F14
(bronchial asthma with chest pain)
lasted from half an
hour to al daysubsternal pressure
bronchial
asthma+1232723F15
lasted al dayleft upper chestpressure
bronchial
asthma-157474M16
lasted al day
substernal pressure
induced by
deep inspiration
bronchial
asthma+9262929M17
(non-asthmatic alergic chest pain)
lasted al daysubsternal pressurechildhoodasthma+2501717F18
lasted al daysubsternal pressuresarcoidosis-44747F19
lasted a few seconds, 
many times a daysubsternal pressure+1422926F20
† UniCAP specific IgE, Fluoroenzymeimmunoanalyses specific immunoglobulin E.
Three patients (cases 15, 16, and 17) were previ-
ously diagnosed with bronchial asthma, and three pa-
tients (cases 2, 8, and 18) had a history of childhood
asthma. Other patients were suffering from atopic
dermatitis (case 1), allergic rhinitis (case 10), and
sarcoidosis (case 19). Two patients (cases 1 and 6)
experienced chest pain attacks only in the morning,
while five patients (cases 3, 4, 10, 12, and 20) experi-
enced pain at various times throughout the day.
Smoking induced attacks were observed in two pa-
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Table 2 Characteristics of chest pain relieved with asthma drugs in twenty patients (2)
Change in the
pulmonary function
between the initial 
phase and the
stable phase 
after treatment
Bronchodilator test at chest painFlow volume
curve patern
at first
examination
Wheezing
during
chest
pain atack
Dyspnea
atack
without
wheezing 
Typical
asthma
atack
No.
Change
in PEF ‡
Change
in
FEV1†
Change
in
PEF ‡
Change
in
FEV1†
Change of
chest pain
(chest pain variant asthma)
0%0%disappearednormal--- 1
-2%-7%0%10%disappearedobstruction--- 2
45%0%44%-2%disappeared
severe central
airway
obstruction
--- 3
15%12%6%4%improvedobstruction--- 4
211%55%6%3%disappeared
severe central
airway
obstruction
--- 5
disappeared
severe central
airway
obstruction
-+- 6
impossible for 
chest painimproved
severe central
airway
obstruction
--- 7
48%-4%23%6%disappeared
mild central
airway
obstruction
--- 8
-3%3%improvednormal--- 9
28%8%disappeared
mild central
airway
obstruction
---10
51%11%disappearedsevereobstruction---11
9%18%improvedsevereobstruction---12
28%14%disappearednormal---13
0%4%disappearednormal---14
(bronchial asthma with chest pain)
no changeobstruction--+15
no changesevereobstruction--+16
14%7%no changenormal--+17
(non-asthmatic alergic chest pain)
no changenormal---18
no change
mild central
airway
obstruction
---19
no changenormal---20
† FEV1, forced expiratory volume in one second.
‡ PEF, peak expiratory flow.
tients (cases 2 and 10). The duration of chest pain
varied from a few seconds to months, and the level of
pain varied from mild to severe and immobilizing.
Two patients (cases 4 and 6) had attacks of dyspnea
with no wheezing that were not related to the chest
pain attacks. None of the patients showed signs of
wheezing during the chest pain attacks.
Inhalation of a short-acting β2-stimulant improved
the chest pain attacks in fourteen patients; there was
no improvement in the remaining six patients (Table
2). Interestingly, treatment of five patients with a
bronchodilator, steroids, and leukotriene receptor an-
Chest Pain Relieved with Asthma Drugs
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Table 3 Measurement of bronchial hyperesponsiveness 
to histamine in seven patients with chest pain variant asthma
Symptom induced by testPD20FEV1No.
chest pressure  264 mcg 5
chest discomfort  118 mcg 7
no symptom3,632 mcg 8
chest pressure6,526 mcg 9
no symptom1,779 mcg10
no symptom4,981 mcg11
chest pressuremore than 20,000 mcg13
tagonist therapy, all had a greater effect on the peak
flow rate than on the forced expiratory volume in one
second (cases 3, 5, 8, 10, and 11). In addition, many
chest pain variant asthma patients showed a central
airway obstruction pattern during their chest pain at-
tacks that improved after treatment with a bronchodi-
lator. The chest pain attacks improved in two patients
(cases 1 and 9) after the inhalation of a bronchodila-
tor, although there was no change in the pulmonary
function tests conducted before and after the inhala-
tion of the bronchodilator. In case 3, the right head
pressure during an attack was due to the radiation of
chest pain; the head pressure was relieved after the
inhalation of a bronchodilator.
Measurements of bronchial hyperresponsiveness
to histamine8 were carried out in seven patients with
chest pain variant asthma; six patients tested positive
(Table 3). The bronchial hyperresponsiveness tests
induced chest pain attacks in three patients (cases 5,
9, and 13) and chest discomfort in one (case 7). Non-
steroidal anti-inflammatory drugs were effective
against chest pain for several hours in three patients.
In many patients, a leukotriene receptor antagonist
provided very effective long-term control (Table 4).
Indeed, leukotriene receptor antagonists are thought
to be more effective than systemic corticosteroids in
many patients. Inhaled corticosteroids and inhaled
β2-stimulants were administered to patients with air-
way constrictive conditions, such as chest pain vari-
ant asthma and bronchial asthma.
DISCUSSION
The chest pain experienced by twenty patients and
relieved with asthma drugs was classified into one of
the following three types: “chest pain variant
asthma,” “bronchial asthma with chest pain,” and
“non-asthmatic allergic chest pain.”
Whitney and co-workers2 reported on three pa-
tients presenting with chest pain that was relieved
with a bronchodilator, who were diagnosed as having
asthma. This disease was termed “chest pain variant
asthma,” and several articles in the medical literature
have now addressed this disease.1-7 There are no
clear diagnostic criteria established for chest pain
variant asthma, but it should be defined as chest pain,
without the characteristic attacks of bronchial
asthma, that improves with the use of a bronchodila-
tor. Challenging patients with inhalation of a bron-
chodilator during an attack of chest pain can be very
useful in the diagnosis of this condition. In the cur-
rent study, histamine inhalation challenges were per-
formed in seven patients with chest pain variant
asthma, of which six showed a positive response. In-
terestingly, these challenges induced chest pressure
or discomfort in some patients. There is little doubt
that the chest pressure was induced by constriction
of the airway in the chest pain variant asthma pa-
tients; the pressure lessened in response to admini-
stration of a bronchodilator in concordance with
bronchodilation and bronchoconstriction induced by
histamine provoked chest pain in some patients.
However the precise mechanisms of chest pain have
not been elucidated. Case 13 showed a negative re-
sponse to histamine inhalation challenges in spite of
chest pressure. We speculate that his airway constric-
tion after the histamine inhalation challenge was not
sufficient to decrease his forced expiratory volume in
one second by 20%, but was sufficient to induce chest
pressure.
Bronchial asthma should be defined as reversible
bronchial obstruction and airway hyperresponsive-
ness. The pathognomonic symptoms of this disease
are reversible coughing, inspiratory wheezing, and
dyspnea. Edmondstone9 reported that patients admit-
ted with acute asthma had experienced chest pain.
Chest pain occurred in 76% of the patients examined
herein, where it was characteristically observed as
either a dull ache or a sharp stabbing pain in the ster-
nal or subcostal areas. Chest pain usually occurs dur-
ing asthma attacks. On occasion, patients experience
continuous or repeated chest pain regardless of
whether a typical asthma attack is in progression, as
in cases 15, 16, and 17 in the current study.
In 1973, Farr et al.10 described an asthmatic patient
with chest tightness without wheezing that was re-
lieved with a bronchodilator. This case should be di-
agnosed as “bronchial asthma with chest pain” be-
cause it demonstrated a typical asthma attack. The
chest pressure in this case was likely induced by the
constriction of the airway, since the chest pressure
was reduced (improved) after administration of a
bronchodilator. In the current study, three cases
showed bronchial asthma with chest pain. These
three patients experienced a typical asthma attack
with wheezing on some occasion. However their
chest pressure was not induced by increased con-
striction. Their chest pressure was not induced due
to increased constriction of the airway, because it was
not reduced (improved) in response to the bron-
chodilator in contrast to the report by Farr et al. How-
ever, the chest pressure in these three patients was
induced via an allergic or other mechanisms related
to leukotrienes, because the pressure was improved
Taniguchi H et al.
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Table 4 Treatment of chest pain with asthma drugs in twenty patients
NSAID for chest 
pain
Long term control drug
No.
THEOLABALTRAICSOCS
(chest pain variant asthma)
OO 1
O 2
O 3
OO 4
efectiveOOO 5
OOOO 6
efectiveOOOO 7
O 8
OO 9
O10
OO11
OO12
OO13
O14
(bronchial asthma with chest pain)
efectiveOOOOO15
OOOOO16
OO17
(non-asthmatic alergic chest pain)
OO18
O19
O20
LTRA, leukotriene receptor antagonist; ICS, inhaled corticosteroids; OCS, oral corticosteroids; THEO, theophyline; LABA, long-acting 
beta 2-adrenergic agonists; NSAID, non-steroidal anti-inflammatory drug.
by the administration of a leukotriene receptor an-
tagonist. This suggests that the chest pain associated
with bronchial asthma can occur via two pathways: a
pathway involving airway constriction or a pathway
involving a non-constriction mechanism. The fact that
a leukotriene receptor antagonist is more effective for
chest pain than other asthma drugs suggests evi-
dence in support of the latter mechanism.
There was another group of chest pain that lasted
all day and was relieved with a leukotriene receptor
antagonist or systemic corticosteroid, but not with a
bronchodilator. These three patients did not have
either bronchial asthma or chest pain variant asthma.
Their chest pressure may have been induced by aller-
gic mechanisms, or other mechanisms involving leu-
kotrienes, but it was not associated with constriction
of the airway. This condition was defined herein as
“non-asthmatic allergic chest pain”, although it is pos-
sible that there are exceptional cases with non-
allergic mechanisms. A leukotriene receptor antago-
nist is very effective in treating chest pain in patients
with non-asthmatic allergic chest pain, in contrast to
other asthma drugs, such as systemic corticosteroids.
The mechanism underlying the development of
chest pain that can be relieved with asthma drugs is
unclear at this time; it may be induced either by an
airway constriction mechanism or by a non-
constriction pathway, as mentioned previously. Ed-
mondstone9 speculated that the mechanism of chest
pain related to asthma attacks is of musculoskeletal
origin, but we suspect that the current cases with
continuous or repeated chest pressure developed
chest pain through other mechanisms. A pulmonary
function test performed during the pain attack in five
patients (cases 3, 5, 8, 10, and 11) with airway con-
striction showed a severe central airway obstruction
pattern that improved with the use of the bronchodi-
lator.4 In these cases, the chest pain was induced in
the comparatively large airways, such as the trachea.4
As such, the patients with chest pain associated with
an airway constriction pathway showed no wheezing
during the chest pain attack, and many of them
showed substernal pain. In two patients (cases 1 and
9), a pulmonary function test, performed during the
attack, showed no significant changes after the use of
the bronchodilator. The constriction on the large air-
ways would be too weak to be reflected in the pulmo-
nary function test. Patients suffering from chest pain
with airway constriction and without airway constric-
tion show similar symptoms. Changes in the pulmo-
Chest Pain Relieved with Asthma Drugs
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nary function between the initial phase and the stable
phase after a few months of treatments are important
because airflow obstruction is sometimes observed,
as shown case 5. It is difficult to distinguish between
these two types of chest pain symptomatically. There-
fore, it is possible that the two pathways are associ-
ated with the same airways and components of the
nervous system. We speculate that the cause of chest
pain without airway constriction involves inflamma-
tion of the airways, and that leukotrienes are associ-
ated with this pathway.
Chest pain variant asthma could be associated with
chronic inflammation in the airway and correspond-
ing airway constriction. Patients with chest pain vari-
ant asthma should be treated in the same manner as
those with typical asthma.4-7 Patients with bronchial
asthma with chest pain should also be treated in the
same manner as those with typical asthma, but we
recommend the addition of a leukotriene receptor an-
tagonist. It is possible to treat patients with non-
asthmatic allergic chest pain with only a leukotriene
receptor antagonist; this may be sufficient to control
chest pain. However, if this treatment proves inade-
quate, a systemic corticosteroid should be pre-
scribed. A subset of the chest pain variant asthma pa-
tients still presented with chest pain after treatment
with a bronchodilator; their chest pain was abolished
with the administration of a leukotriene receptor an-
tagonist. This suggests that the chest pain in this sub-
set of chest pain variant asthma patients is comprised
of an airway non-constriction pathway component.
Although most patients who experience chest pain
consult physicians, many of them remain undiag-
nosed. Almost half of the patients in the current study
were diagnosed by other physicians as having variant
angina, psychogenic problems, esophageal reflex, or
cramps of the intercostal muscles. Chest pain variant
asthma and bronchial asthma with chest pain are dif-
ficult to diagnose because they are poorly character-
ized diseases. In addition, non-asthmatic allergic
chest pain is a novel condition. Chest pain that was
relieved with asthma drugs has been diagnosed in
twenty patients at the Toyama Prefectural Central
Hospital, indicating that this clinical condition is not
uncommon. Treatment with a bronchodilator and a
leukotriene receptor antagonist should be considered
for patients with chest pressure of unknown etiology.
Obviously, it is critical to eliminate coronary disease
before inhalation of a β2-stimulant. There is an appar-
ent need for increased dissemination of knowledge
concerning the chest pain that is relieved with
asthma drugs.
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